As of 2026-04-01, 泽布替尼（百悦泽）'s data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 2.90%, above the industry average by 1.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (2.90%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, 泽布替尼（百悦泽）'s overall mention rate surpasses 5 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
泽布替尼（百悦泽）'s Mention Rate is 2.90%, lower than 0.6% of competitors
泽布替尼（百悦泽）'s First Mention is 0.00%, lower than 0.9% of competitors
泽布替尼（百悦泽）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
泽布替尼（百悦泽）'s Positive Rate is 2.90%, lower than 8.9% of competitors
泽布替尼（百悦泽）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| KKeytruda | 8.7% | 0% | 0% | 4.35% | 2.9% | View Details |
| 泽泽布替尼（百悦泽） (Current Brand) | 2.9% | 0% | 0% | 2.9% | 0% | View Details |
| KKeytruda（K药） | 1.45% | 0% | 0% | 1.45% | 1.45% | View Details |
| EEnhertu | 1.45% | 0% | 0% | 0% | 0% | View Details |
| 卡卡瑞利珠单抗 | 1.45% | 0% | 0% | 0% | 0% | View Details |
| ZZepbound | 0% | 0% | 0% | 0% | 0% | View Details |
| DDarzalex（达雷妥尤单抗） | 0% | 0% | 0% | 0% | 0% | View Details |
